Attovia Therapeutics’ $90 Million Series C Funding Round

Leila Ahmed North America Legal Chronicle
Tagged:

Fenwick & West represented Attovia Therapeutics in the transaction. Attovia Therapeutics, a clinical-stage biopharma company developing treatments for immune-mediated diseases, announced it raised $90 million in…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here